Sort
48,018 grants matching “immunotherapy”
The role of Nrf2 in mediating resistance to EGFR inhibition in glioblastoma
$367,645Amyn Habib · Ut Southwestern Medical Center · R01 · FY2022 · CA
Botswana CASCADE Clinical Trials Site
$367,640Scott Dryden-Peterson · Brigham And Women'S Hospital · UG1 · FY2024 · CA
OSTEOCLASTS AND BONE CANCER
$367,638University Of Minnesota Twin Cities · R01 · FY2003 · AR
OSTEOCLASTS AND BONE CANCER
$367,609University Of Minnesota Twin Cities · R01 · FY2004 · AR
Normalizing PDAC stroma with PCBP2 siRNA nanoparticles to improve the antitumor activity of chemotherapy and immunotherapy
$367,571Kun Cheng · University Of Missouri Kansas City · R01 · FY2025 · CA
Transcriptional and epigenetic mechanisms of immunotherapy resistance in melanoma
$367,559Kai W Wucherpfennig · Massachusetts General Hospital · P01 · FY2020 · CA
Transcriptional and epigenetic mechanisms of immunotherapy resistance in melanoma
$367,559Kai W Wucherpfennig · Massachusetts General Hospital · P01 · FY2021 · CA
A Critical Role for the Microvasculature in Airway Transplantation
$367,556Mark Robert Nicolls · Palo Alto Veterans Instit For Research · R01 · FY2010 · HL
Active Hyaluronan Polymer Brushes for Tunable Biointerfaces
$367,552Jennifer Curtis · Georgia Tech Research Corporation · · FY2017 · MPS
CANCER AND LEUKEMIA GROUP B--RPCI/SUNYAB
$367,544Roswell Park Cancer Institute Corp · U10 · FY2002 · CA
Biobehavioral Role of Brain Kynurenine Metabolism in Mental Illness
$367,538Jason C O'Connor · University Of Texas Hlth Science Center · R01 · FY2011 · MH
Understanding Immunopathogenesis of Hepatitis B Virus
$367,527Jody L Baron · University Of California, San Francisco · R01 · FY2008 · AI
Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy
$367,506Abraham P Lee · University Of California-Irvine · R33 · FY2022 · CA
ATR Dependency as a Novel Therapeutic Target in Lethal RB Deficient ProstateCancer
$367,506Leigh Ellis · Cedars-Sinai Medical Center · R01 · FY2021 · CA
T cell regulation by IDO-competent plasmacytoid dendritic cells
$367,500Andrew Lee Mellor · Augusta University · R01 · FY2009 · AI
Protective Host Immunity Against Pulmonary Cryptococcosis
$367,500Floyd L. Wormley · University Of Texas San Antonio · R01 · FY2014 · AI
Protective Host Immunity Against Pulmonary Cryptococcosis
$367,500Floyd L. Wormley · University Of Texas San Antonio · R01 · FY2016 · AI
Regulation of T cell activity during chronic infections
$367,500Allan J Zajac · University Of Alabama At Birmingham · R01 · FY2017 · AI
Regulation of T cell activity during chronic infections
$367,500Allan J Zajac · University Of Alabama At Birmingham · R01 · FY2016 · AI
T cell regulation by IDO-competent plasmacytoid dendritic cells
$367,500Andrew Lee Mellor · Augusta University · R01 · FY2010 · AI
Protective Host Immunity Against Pulmonary Cryptococcosis
$367,500Floyd L. Wormley · University Of Texas San Antonio · R01 · FY2015 · AI
Regulation of T cell activity during chronic infections
$367,500Allan J Zajac · University Of Alabama At Birmingham · R01 · FY2018 · AI
Regulation of T cell activity during chronic infections
$367,500Allan J Zajac · University Of Alabama At Birmingham · R01 · FY2019 · AI
Role of B-cell mediated anti-tumor antibodies in responses to radiation and immunotherapy in HNSCC
$367,469Andrew B. Sharabi · University Of California, San Diego · R01 · FY2023 · DE
Clinical Trials and Translation
$367,442Julie R Park · Children'S Hosp Of Philadelphia · P01 · FY2020 · CA